Introduction

Nigeria has taken a significant step forward in malaria prevention by commencing local production of next-generation dual-active ingredient insecticide-treated mosquito nets. The initiative, led by Health Textiles Nigeria FZE under the Vestergaard brand, aims to strengthen domestic manufacturing and reduce the country's heavy malaria burden.

What Happened

The Federal Ministry of Health and Social Welfare announced the development in a statement signed by Assistant Director Ado Bako. The new facility, Health Textiles Nigeria FZE, is the first in Nigeria to manufacture dual-active ingredient insecticide-treated nets. It will produce PermaNet Dual, a WHO-prequalified product addressing the growing challenge of insecticide resistance. At full capacity, the plant is expected to produce approximately 10 million nets annually and create more than 600 jobs, with roughly 80 staff members currently undergoing training in manufacturing protocols, quality assurance, workplace safety, and compliance standards.

Why This Matters

World Health Organisation data from 2024 shows malaria resulted in 282 million cases and 610,000 deaths globally, with the African Region bearing the brunt of the burden. Local production of dual-active ingredient nets reduces reliance on imports, directly addresses insecticide resistance, and supports the Nigeria Health Sector Renewal Investment Initiative. It also represents a major step toward strengthening the nation's healthcare value chain and improving access to affordable, effective malaria prevention tools.

Key Takeaways

  • Health Textiles Nigeria FZE will produce approximately 10 million dual-active ingredient mosquito nets annually at full scale.
  • The facility has already created over 600 jobs, with roughly 80 staff members currently in training.
  • PermaNet Dual is prequalified by the World Health Organisation, ensuring quality and efficacy.
  • Local production aligns with the Nigeria Health Sector Renewal Investment Initiative and reduces import dependency.
  • First commercial orders are expected in the coming months, expanding Nigeria's capacity to manufacture essential health products domestically.

Conclusion

The commencement of local production marks a pivotal moment in Nigeria's fight against malaria. By combining government policy, private-sector investment, and technology transfer, the initiative promises to improve malaria prevention access, lower costs, and bolster the domestic manufacturing ecosystem. Stakeholders and citizens should anticipate the rollout of these nets and the positive impact on public health in the months ahead.